Abstract The scientific journal Nature Methods have just retracted a publication that reported numerous unexpected mutations after a CRISPR-Cas9 experiment based on collecting whole genome sequencing information from one control and two experimental genome edited mice. In the intervening 10 months since publication the data presented have been strongly contested and criticized by the scientific and biotech communities, through publications, open science channels and social networks. The criticism focused on the animal used as control, which was derived from the same mouse strain as the experimental individuals but from an unrelated sub-colony, hence control and experimental mice were genetically divergent. The most plausible explanation for the vast majority of the reported unexpected mutations were the expected underlying genetic polymorphisms that normally accumulate in two different colonies of the same mouse strain which occur as a result of spontaneous mutations and genetic drift. Therefore, the reported mutations were most likely not related to CRISPR-Cas9 activity.
On 30th May 2017, the scientific journal Nature Methods released a publication with a striking title: unexpected mutations after a CRISPR-Cas9 editing in vivo (Schaefer et al. 2017a) . The study addressed the issue of potential off-target mutations triggered after an experiment with CRISPR-Cas9 in vivo using genome edited mice. The same group had previously described the mice, where a specific nonsense point mutation on the Pde6b gene had been corrected by using a CRISPR-Cas9 approach. This work elegantly defined the underlying molecular cause of the rd1 mutant mice, a classical animal model for investigating retinitis pigmentosa (Wu et al. 2016 ). The authors then applied Next-Generation-Sequencing (NGS) techniques to obtain the whole genome sequence (WGS) from experimental (CRISPR-derived) and control (unrelated mice from the same inbred strain: FVB/NJ) individuals and compared the outcome. Their bioinformatic analyses revealed the existence of approximately 1700 genetic variants, most of them shared between the experimental CRISPR-derived mice, in comparison to the control sample, after filtering for common known genetic polymorphisms associated with mouse inbred strains that had been sequenced (Adams et al. 2015) . Surprisingly, none of these genetic variants was associated with any of the bioinformatically predicted potential off-target sites. The authors then concluded that much additional work was still needed before considering CRISPR-Cas9 approaches for their safe applications in clinical settings (Schaefer et al. 2017a) .
Almost immediately the publication by Schaefer et al. triggered enormous controversy among the scientific community and more broadly among society in general. The assumed identification of numerous unexpected off-target mutations after a CRISPR-Cas9 experiment in vivo suggested that genome editing approaches by using CRISPR tools would probably be unsafe for clinical applications. The study generated concern and disappointment among the patient associations of congenital diseases, which had been hoping that genome editing would soon result in safe, efficient and innovative gene therapy solutions for many genetic conditions currently without a cure. Similar concerns could be underlined for other CRISPR-Cas9 derived biotechnological applications, for the generation of new genome edited animals and plants with improved disease resistance, adaptation to the environment or increased beneficial nutritional parameters (Tan et al. 2016) . Not surprisingly, one of first consequences noted was the loss in stock value for several companies aiming to commercialize CRISPRderived applications (Begley 2017) .
Simultaneously, the scientific community also reacted and within days, thanks to social networks and open science channels, heavily began to question the experimental design and the interpretation of the data of the controversial study. At first, these numerous mutations had not been found in numerous previously reported CRISPR-Cas9 in vivo experiments in mice, either by directly sequencing predicted off-target positions (Seruggia et al. 2015) or even after applying genome-wide systematical NGS approaches (Iyer et al. 2015; Nakajima et al. 2016) .
Gaetan Burgio was among the first researchers to release a critical commentary on the study in Nature Methods through a blog (Burgio 2017 ). Burgio highlighted the important fact that only two CRISPR-derived experimental and one single control mice were reported in the original study, a sample size which is recognized as well below optimal. He also pointed to the fact that persistent Cas9 expression (the authors injected a DNA plasmid expressing the nickase Cas9 version) could have possibly contributed to some of the observed genetic variants. Even more importantly, Burgio was also the first to recognize that the bioinformatic analysis was suboptimal and crucially did not take into consideration natural genetic variation that was present in the mouse colony used, in addition to de novo mutations, would be a more likely explanation for the reported results (Burgio 2017) .
Within 2 months from the Schaefer et al. publication in Nature Methods, numerous studies were deposited in the public repository bioRxiv (https:// www.biorxiv.org) with alternative explanations for the origin of the reported unexpected mutations. All these studies highlighted the lack of proper parental (and hence) closely genetically-related controls which should have been used. More analysis of the mouse genetic backgrounds involved in the study would likely indicate that the unexpected reported mutations are most likely unrelated to CRISPR-Cas9 activity.
Subsequently, the original authors Shaefer et al. deposited two additional manuscripts in bioRxiv each destined for eventual publication. First, in July, after the initial wave of rebuttal responses deposited from academia and the commercial sector, the authors provided some additional sequencing data and explanations-but crucially without withdrawing the original study-further elaborating on the complexities of the approach and anticipating the wider range of WGS controls that would be required to adequately assess the data for potential off-target mutations (Schaefer et al. 2017b ). Second, the same team deposited yet another unrelated study, involving two additional independent CRISPR-Cas9 experiments in mice. They reported the result of new WGS analyses by comparing genome edited individuals with control mice from the parental mouse strain, not exactly the progenitors but within a few generations of the edited individuals. Importantly, they now did not find the equivalent unexpected variants in clear contradiction to their study from the previous year (Schaefer et al. 2018 ). Nevertheless, the authors still argued that the limited number of variants detected in their more recent studies, supported the notion that causes beyond genetic drift would be required to explain the larger number of genetic variants found in their 2017 original study.
Five of the articles rebutting the initial observations by Schaefer et al. that had been deposited in bioRxiv were eventually accepted for publication in Nature Methods on 30 March 2018 (Kim et al. 2018; Lareau et al. 2018; Lescarbeau et al. 2018; Nutter et al. 2018; Wilson et al. 2018) , 10 months after the publication of the original Schafer et al. study. These rebuttal publications appeared on the same day that the controversial study was retracted online by the journal itself, with the approval of two of the authors and the disagreement of the rest, including first and last authors. As stated in the Editorial retraction note: ''This paper is being retracted because the genomic variants observed by the authors in two CRISPRtreated mice cannot be conclusively attributed to CRISPR-Cas9'' (Nature Methods Editorial 2018).
Spontaneous mutations constantly occur and accumulate in any living organism. Recent studies in mice suggest that * 100 heterozygous single-nucleotidevariants (SNPs) are accumulated per generation (Uchimura et al. 2015) . Upon breeding and segregating, distinct mutations are fixed in different groups of individuals, due to the well-known effect of the genetic drift (Stevens et al. 2007 ). This is the origin of genetic diversity, including that of the underlying numerous genetic variants found in common laboratory mouse inbred strains (Zurita et al. 2011) (Fig. 1) . Therefore, the most plausible explanation for the origin of most of the * 1700 genetic variants reported by the Schaefer et al. study would be the pre-existing genetic differences between individuals of apparently the same mouse genetic strain (FVB/NJ) but selected from unrelated mouse sub-colonies. As indicated in the Editorial retraction note: ''The authors used mice of the inbred FVB/NJ strain from the JAX genetic quality control program that were purchased within months of each other and that were not bred in the authors' laboratory''. Hence, the observed mutations would most likely be the result of spontaneous mutations and genetic drift rather than associated with off-target CRISPR-Cas9 activity as was initially announced.
A more careful experimental design addressing the potential off-target issue after CRISPR-Cas9 in vivo editing in mice was conducted by Iyer et al., and deposited in the bioRxiv preprint repository on 9 February 2018 (Iyer et al. 2018) . Here, the authors used a robust trio design to compare WGS from the parents of CRISPR-Cas9 in vivo experiment in mice with the resulting genome edited mouse embryos. In this study, no statistically significant differences were found between the accumulation of presumptive offtarget mutations possibly related to CRISPR-Cas9 activity and those that would be usually expected due to the normal rate of de novo mutations. This manuscript unequivocally demonstrates that the use of properly selected mouse controls in genome editing experiments in vivo is essential.
This story also includes a lesson on research responsibility-the need for good experimental Fig. 1 Scheme illustrating the occurrence and segregation of spontaneous mutations in two mouse colonies from the same inbred strain but bred independently. Genetic drift results in distinct genetic variants accumulated in different mouse breeding colonies. These are genetically divergent, among them, but also in comparison with the original parental mouse strain from which they are both derived design. In this case, the appropriate use of controls. Responsibility also falls on publishers to robustly review manuscripts, particularly when these conclusions are expected to generate an enormous impact and are contradictory to previous knowledge reported from similar experiments. Extraordinary claims require extraordinary and convincingly robust evidences. Publishers should pride themselves in communicating reproducible science.
Scientific developments and advances are often quickly discussed outside the traditional communication channels, beyond the standard peer-reviewed scientific publications. This story nicely illustrates the great power of current Open Science projects like bioRxiv, the public repository of preprints, scientific blogs and social networks, which were all instrumental to rapidly disseminate comments and to discuss the accuracy and soundness of any publication released or manuscript deposited. Scientific journals and publishers should take good note of this.
